☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Insomnia
Neurological Clinical Trial Trends Under Pandemic and Changing Geopolitics
November 8, 2022
Eisai's Dayvigo (lemborexant) Receives the US FDA's Approval to Treat Insomnia in Adults
December 23, 2019
Eisai and Purdue Report Result of Lemborexant in P-III SUNRISE 2 Study for Insomnia in Adults
February 5, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.